Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease

Affiliations

Editorial

Andrea Shin. Aliment Pharmacol Ther. 2022 Oct.

. 2022 Oct;56(8):1300-1301.

doi: 10.1111/apt.17211.

¹ Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.

No abstract available

Comment in

Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease-authors' reply.
Fairbrass KM, Hamlin PJ, Gracie DJ, Ford AC. Fairbrass KM, et al. Aliment Pharmacol Ther. 2022 Oct;56(8):1302-1303. doi: 10.1111/apt.17215. Aliment Pharmacol Ther. 2022. PMID: 36168260 No abstract available.

Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 6 years of longitudinal follow-up.
Fairbrass KM, Hamlin PJ, Gracie DJ, Ford AC. Fairbrass KM, et al. Aliment Pharmacol Ther. 2022 Oct;56(8):1264-1273. doi: 10.1111/apt.17193. Epub 2022 Aug 22. Aliment Pharmacol Ther. 2022. PMID: 35995729

1. Fairbrass KM, Costantino SJ, Gracie DJ, Ford AC. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:1053-62.
1. Gracie DJ, Hamlin JP, Ford AC. Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease. Am J Gastroenterol. 2018;113:702-12.
1. Trieschmann K, Chang L, Park S, Naliboff B, Joshi S, Labus JS, et al. The visceral sensitivity index: a novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease. Neurogastroenterol Motil. 2022;e14384. https://doi.org/10.1111/nmo.14384 [Online ahead of print].
1. Midenfjord I, Grinsvall C, Koj P, Carnerup I, Törnblom H, Simrén M. Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease. Neurogastroenterol Motil. 2021;33:e14156.
1. Moraes L, Magnusson MK, Mavroudis G, Polster A, Jonefjäll B, Törnblom H, et al. Systemic inflammatory protein profiles distinguish irritable bowel syndrome (IBS) and ulcerative colitis, irrespective of inflammation or IBS-like symptoms. Inflamm Bowel Dis. 2020;26:874-84.